Published in N Engl J Med on November 13, 2003
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients | NCT03847311
Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med (2010) 11.99
Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci U S A (2015) 9.32
Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ (2006) 6.12
Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario. Can Fam Physician (2011) 4.13
De facto long-term opioid therapy for noncancer pain. Clin J Pain (2008) 3.85
Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf (2009) 3.25
Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. Can Fam Physician (2011) 2.69
Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain (2010) 2.44
Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med (2010) 2.43
The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev (2009) 2.35
Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther (2005) 2.28
Changes in illicit opioid use across Canada. CMAJ (2006) 2.20
A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy. Eur J Pain (2014) 2.03
Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract (2007) 2.02
Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain (2008) 1.98
Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain (2010) 1.97
Long-term opioid contract use for chronic pain management in primary care practice. A five year experience. J Gen Intern Med (2007) 1.89
Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend (2012) 1.85
Dissociable influences of opiates and expectations on pain. J Neurosci (2012) 1.81
Neuropathic pain: a practical guide for the clinician. CMAJ (2006) 1.79
Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J Pain (2008) 1.74
Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: a patient-initiated study. Br J Gen Pract (2007) 1.54
[Risk assessment in pain therapy]. Schmerz (2008) 1.52
Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain. JAMA (2016) 1.50
Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology (2011) 1.50
Brief report: Training internists in shared decision making about chronic opioid treatment for noncancer pain. J Gen Intern Med (2006) 1.41
Addressing the intersecting problems of opioid misuse and chronic pain treatment. Exp Clin Psychopharmacol (2008) 1.38
Prescription opioid analgesics increase the risk of depression. J Gen Intern Med (2013) 1.37
Prescription opioid analgesics rapidly change the human brain. Pain (2011) 1.34
Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol (2008) 1.32
Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat Rev Rheumatol (2010) 1.29
Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain (2009) 1.27
Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them. Pain Med (2011) 1.25
Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? J Pain Res (2013) 1.20
Current aproach to cancer pain management: Availability and implications of different treatment options. Ther Clin Risk Manag (2007) 1.17
Nocturia: a blinded, randomized, parallel placebo-controlled self-study of the effect of 5 different sedatives and analgesics. Can Urol Assoc J (2008) 1.16
Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation. Med Care (2014) 1.16
Predictors of long-term opioid use among patients with painful lumbar spine conditions. J Pain (2009) 1.14
Gender differences in risk factors for aberrant prescription opioid use. J Pain (2009) 1.13
Opiates and elderly: use and side effects. Clin Interv Aging (2008) 1.10
Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain (2009) 1.09
Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug Alcohol Depend (2010) 1.07
Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada. BMC Health Serv Res (2011) 1.06
Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry (2012) 1.06
Policy-relevant research: when does it matter? NeuroRx (2004) 1.04
Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain (2012) 1.02
Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol (2010) 1.01
Pharmacologic management of chronic pain. Korean J Pain (2010) 0.99
Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage (2008) 0.95
Opioid prescribing in the UK: can we avert a public health disaster? Br J Pain (2012) 0.94
Combination drug therapy for chronic pain: a call for more clinical studies. J Pain (2010) 0.94
Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011. Am J Public Health (2014) 0.94
Opioids for persistent non-cancer pain. BMJ (2005) 0.93
Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United States. BMC Palliat Care (2010) 0.92
Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure. Health Serv Outcomes Res Methodol (2012) 0.92
A review of opioid prescribing practices and associations with repeat opioid prescriptions in a contemporary outpatient HIV clinic. Pain Pract (2011) 0.90
[Long-term efficiency of opioid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment]. Schmerz (2005) 0.90
Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco. AIDS Behav (2014) 0.89
The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone. Neuropsychopharmacology (2010) 0.88
Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence. J Subst Abuse Treat (2007) 0.87
Associations among pain, non-medical prescription opioid use, and drug overdose history. Am J Addict (2013) 0.87
The Efficacy and Clinical Safety of Various Analgesic Combinations for Post-Operative Pain after Third Molar Surgery: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.86
Informed consent in opioid therapy: a potential obligation and opportunity. J Pain Symptom Manage (2012) 0.85
The analgesic and toxic effects of nornicotine enantiomers alone and in interaction with morphine in rodent models of acute and persistent pain. Pharmacol Biochem Behav (2009) 0.85
Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women. Am J Obstet Gynecol (2016) 0.85
Analgesia or addiction?: implications for morphine use after spinal cord injury. J Neurotrauma (2012) 0.84
Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study. Ann Fam Med (2010) 0.84
Commentary on Boscarino et al. (2010): Understanding the spectrum of opioid abuse, misuse and harms among chronic opioid therapy patients. Addiction (2010) 0.83
Managing pain in high-risk patients within a patient-centered medical home. Transl Behav Med (2012) 0.83
Morphinofobia: the situation among the general population and health care professionals in North-Eastern Portugal. BMC Palliat Care (2010) 0.82
Chronic methadone treatment and repeated withdrawal impair cognition and increase the expression of apoptosis-related proteins in mouse brain. Psychopharmacology (Berl) (2007) 0.82
[Risk factors for substance abuse and dependence in opioid therapy for chronic noncancer-related pain]. Schmerz (2005) 0.82
Lack of correlation between opioid dose adjustment and pain score change in a group of chronic pain patients. J Pain (2013) 0.81
Problematic prescription opioid use in an HIV-infected cohort: the importance of universal toxicology testing. J Acquir Immune Defic Syndr (2012) 0.81
Treating chronic pain: new knowledge, more choices. Perm J (2005) 0.81
Systemic morphine treatment induces changes in firing patterns and responses of nociceptive afferent fibers in mouse glabrous skin. Pain (2013) 0.80
Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. Br J Anaesth (2009) 0.80
Psychiatric Comorbidity Is Associated Prospectively with Diminished Opioid Analgesia and Increased Opioid Misuse in Patients with Chronic Low Back Pain. Anesthesiology (2015) 0.80
Opioid pharmacotherapy for chronic noncancer pain: the american experience. Korean J Pain (2013) 0.80
A Multicomponent Intervention to Improve Primary Care Provider Adherence to Chronic Opioid Therapy Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled Trial Protocol. J Subst Abuse Treat (2015) 0.80
Tapentadol in the management of chronic low back pain: a novel approach to a complex condition? J Pain Res (2011) 0.79
Evaluation of the role of opium addiction in acute myocardial infarction as a risk factor. Caspian J Intern Med (2013) 0.79
Screening for addictive disorders within a workers' compensation clinic: an exploratory study. Subst Use Misuse (2011) 0.79
"Safe and effective when used as directed": the case of chronic use of opioid analgesics. J Med Toxicol (2012) 0.78
Evidence-based Clinical Practice Guidelines for Interventional Pain Management in Cancer Pain. Indian J Palliat Care (2015) 0.78
The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review. Pain Ther (2017) 0.78
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. Neuropsychopharmacology (2017) 0.78
Does opioid pain medication use affect the outcome of patients with lumbar disc herniation? Spine (Phila Pa 1976) (2013) 0.78
The Relationship Between Drug Use, Drug-related Arrests, and Chronic Pain Among Adults on Probation. J Subst Abuse Treat (2014) 0.78
Depression and ambivalence toward chronic opioid therapy for chronic noncancer pain. Clin J Pain (2012) 0.78
Functional disability among chronic pain patients receiving long-term opioid treatment. J Soc Work Disabil Rehabil (2012) 0.78
The pharmacological basis of opioids. Clin Cases Miner Bone Metab (2015) 0.78
Use of OROS® hydromorphone in the treatment of osteoarthritis and osteoporosis: A pooled analysis of three non-interventional studies focusing on different starting doses. Wien Klin Wochenschr (2011) 0.78
Morphine self-administration following spinal cord injury. J Neurotrauma (2014) 0.78
Efficacy and safety of post-cesarean section incisional infiltration with lidocaine and epinephrine versus lidocaine alone in reducing postoperative pain: A randomized controlled double-blinded clinical trial. J Turk Ger Gynecol Assoc (2016) 0.78
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. Neuropharmacology (2016) 0.77
Morphine induces hyperalgesia without involvement of μ-opioid receptor or morphine-3-glucuronide. Mol Med (2012) 0.77
Mesenchymal Stem Cells Reversed Morphine Tolerance and Opioid-induced Hyperalgesia. Sci Rep (2016) 0.77
Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci (2003) 2.10
Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest (2012) 1.51
Evidence for a long-term influence on morphine tolerance after previous morphine exposure: role of neuronal glucocorticoid receptors. Pain (2004) 1.48
A rat model of radicular pain induced by chronic compression of lumbar dorsal root ganglion with SURGIFLO. Anesthesiology (2008) 1.48
Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci (2004) 1.32
Neuropathic pain: mechanisms and their clinical implications. BMJ (2014) 1.29
Opioid tolerance and hyperalgesia. Med Clin North Am (2007) 1.28
Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats. Pain (2003) 1.22
Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury. J Neurosci (2005) 1.21
Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain (2009) 1.09
Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J Pain (2013) 1.06
Combination therapy for neuropathic pain: a review of current evidence. CNS Drugs (2011) 1.02
Surgical incision-induced nociception causes cognitive impairment and reduction in synaptic NMDA receptor 2B in mice. J Neurosci (2013) 1.01
Expression of spinal NMDA receptor and PKCgamma after chronic morphine is regulated by spinal glucocorticoid receptor. J Neurosci (2005) 1.01
The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J Pain (2006) 0.98
Exacerbated mechanical allodynia in rats with depression-like behavior. Brain Res (2008) 0.98
The effect of opioid dose and treatment duration on the perception of a painful standardized clinical stimulus. Reg Anesth Pain Med (2008) 0.96
Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents. J Clin Invest (2009) 0.96
Leptin enhances NMDA-induced spinal excitation in rats: A functional link between adipocytokine and neuropathic pain. Pain (2011) 0.95
Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation. J Biol Chem (2008) 0.95
Regulation of the trigeminal NR1 subunit expression induced by inflammation of the temporomandibular joint region in rats. Pain (2008) 0.94
A rat model of unilateral hindpaw burn injury: slowly developing rightwards shift of the morphine dose-response curve. Pain (2005) 0.94
Intrathecal midazolam regulates spinal AMPA receptor expression and function after nerve injury in rats. Brain Res (2006) 0.92
Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats. Pain (2007) 0.90
Notch3 is necessary for neuronal differentiation and maturation in the adult spinal cord. J Cell Mol Med (2014) 0.88
Opioid therapy for chronic pain: physicians' attitude and current practice patterns. J Opioid Manag (2011) 0.87
cAMP and protein kinase A contribute to the downregulation of spinal glutamate transporters after chronic morphine. Neurosci Lett (2004) 0.87
Spinal translocator protein (TSPO) modulates pain behavior in rats with CFA-induced monoarthritis. Brain Res (2009) 0.86
Inhibition of the ubiquitin-proteasome activity prevents glutamate transporter degradation and morphine tolerance. Pain (2008) 0.86
Downregulation of spinal glutamate transporter EAAC1 following nerve injury is regulated by central glucocorticoid receptors in rats. Pain (2005) 0.86
Improved opioid analgesic effect following opioid dose reduction. Pain Med (2008) 0.85
Activity of adenylyl cyclase and protein kinase A contributes to morphine-induced spinal apoptosis. Neurosci Lett (2005) 0.85
Exacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors. Pain (2012) 0.85
A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats. Brain Res (2009) 0.85
Spinal glucocorticoid receptors contribute to the development of morphine tolerance in rats. Anesthesiology (2005) 0.85
Peripheral formalin injection induces unique spinal cord microglial phenotypic changes. Neurosci Lett (2008) 0.83
Nociceptive behavior following hindpaw burn injury in young rats: response to systemic morphine. Pain Med (2010) 0.83
Buprenorphine-naloxone therapy in pain management. Anesthesiology (2014) 0.82
A differential diagnosis of hyperalgesia, toxicity, and withdrawal from intrathecal morphine infusion. Anesth Analg (2007) 0.82
A survey of selected physician views on acupuncture in pain management. Pain Med (2010) 0.81
Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid-1 receptors after peripheral nerve injury in rats. Pain (2007) 0.81
Systemic minocycline differentially influences changes in spinal microglial markers following formalin-induced nociception. J Neuroimmunol (2010) 0.81
An intravenous ketamine test as a predictive response tool in opioid-exposed patients with persistent pain. J Pain Symptom Manage (2008) 0.81
Lack of correlation between opioid dose adjustment and pain score change in a group of chronic pain patients. J Pain (2013) 0.81
Peripheral nerve injury alters the expression of NF-κB in the rat's hippocampus. Brain Res (2011) 0.80
Inflammatory pain may induce cognitive impairment through an interlukin-6-dependent and postsynaptic density-95-associated mechanism. Anesth Analg (2014) 0.79
The intravenous ketamine test: a predictive response tool for oral dextromethorphan treatment in neuropathic pain. Anesth Analg (2004) 0.79
Spatiotemporal pattern of concurrent spinal and supraspinal NF-κB expression after peripheral nerve injury. J Pain (2010) 0.79
Time-dependent effect of epidural steroid on pain behavior induced by chronic compression of dorsal root ganglion in rats. Brain Res (2007) 0.79
Update on neuropathic pain treatment: ion channel blockers and gabapentinoids. Curr Pain Headache Rep (2013) 0.78
Cannabinoid receptor type 1 antagonist, AM251, attenuates mechanical allodynia and thermal hyperalgesia after burn injury. Anesthesiology (2014) 0.78
Pain and opioid addiction: what is the connection? Curr Pain Headache Rep (2010) 0.77
Disruption of persistent nociceptive behavior in rats with learning impairment. PLoS One (2013) 0.77
Central glucocorticoid receptors modulate the expression of spinal cannabinoid receptors induced by chronic morphine exposure. Brain Res (2005) 0.77
Intravenous Ketamine Infusions for Neuropathic Pain Management: A Promising Therapy in Need of Optimization. Anesth Analg (2017) 0.76
Spinal expression of Hippo signaling components YAP and TAZ following peripheral nerve injury in rats. Brain Res (2013) 0.76
Glutamate transporter: an unexpected target for some antibiotics. Mol Pain (2005) 0.76
A functional relationship between trigeminal astroglial activation and NR1 expression in a rat model of temporomandibular joint inflammation. Pain Med (2012) 0.76
Two unusual cases of postamputation pain from Operation Iraqi Freedom. J Trauma (2007) 0.76
N-type calcium channel blocker for pain treatment. Pain Med (2010) 0.76
Effect of 1.5% Topical Diclofenac on Clinical Neuropathic Pain. Anesthesiology (2015) 0.75
Anti-morphine antibody contributes to the development of morphine tolerance in rats. Neurosci Lett (2010) 0.75
Concerns about consensus guidelines for QTc interval screening in methadone treatment. Ann Intern Med (2009) 0.75
Nortriptyline Enhances Morphine-Conditioned Place Preference in Neuropathic Rats: Role of the Central Noradrenergic System. Anesth Analg (2017) 0.75
Ethical challenges and interventional pain medicine. Curr Pain Headache Rep (2012) 0.75
Characterization of nociceptive responses to bee venom-induced inflammation in neonatal rats. Brain Res (2012) 0.75
Multiple Bier blocks with labetalol for complex regional pain syndrome refractory to other treatments. J Pain Symptom Manage (2003) 0.75
Animal models of acute surgical pain. Methods Mol Biol (2010) 0.75